Terumo Medical Corporation

Our Promise At Terumo, everything starts with our unwavering commitment to patients. Listening sincerely to their needs and deeply understanding their hopes and aspirations, we boldly pursue innovative ways to help enhance the lives of patients around the world. Our Promise Story Terumo was founded by a group of physicians and scientists to support the lives of people. Ever since then, we have been doing all we can to advance healthcare and enhance patients’ quality of life. This mindset, expressed in our Group Mission, “Contributing to Society through Healthcare,” drives our continuous transformation to do even more. We will listen sincerely to patients’ needs and deepen our understanding of their hopes and aspirations to discover what will be truly beneficial for them. We will work more closely with healthcare professionals and partners pursuing innovative solutions and ways to advance patient care together. And we will continue to expand our activities and take on new challenges with the thoughts and feelings of patients in mind. We are driven by our desire to help improve patients’ lives. By putting this unwavering commitment into action, we will realize a better future for healthcare and patients.

OrbusNeich Medical Company Ltd.

OrbusNeich is a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells products to over 70 countries and regions worldwide, and it is also the only PCI balloon manufacturer headquartered in China that ranked among the top 6 players in all major overseas PCI balloon markets including Japan, Europe and the U.S. According to an industry research report, in terms of sales volume of PCI balloons in 2021, OrbusNeich held an over 50% share of the PCI balloon market in Hong Kong, and ranked No. 2 in Japan, No. 4 in Europe, No. 6 in the PRC and No. 6 in the U.S . In addition, in terms of sales volume of PTA balloons in 2021, it ranked No. 3 in Japan and No. 4 in the U.S. In addition to PCI/PTA balloons, it also specializes in coronary stent products and is actively expanding into neuro vascular intervention and structural heart disease areas. OrbusNeich owns more than 180 granted patents globally. Its in-house R&D team has over twenty years of product development experience and has developed proprietary, world leading technologies, including its Scoreflex NC product, the world’s smallest profile non-compliant scoring balloon; its proprietary “drug plus antibody” COMBO dual therapy stent; and its JADE non-compliant peripheral balloon, the first and only non-compliant over-the-wire PTA balloon approved by the FDA that is compatible with all guidewire systems in the U.S. OrbusNeich is listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”), under the stock code 6929. For more information and news, visit http://www.orbusneich.com/ or follow us on Twitter @OrbusNeich (Last updated on 23rd Dec 2022)

terumo europe

Terumo Europe is a core player in the EMEA healthcare market by providing best-in-class quality medical products and services. We are a strong actor of the Terumo Group by contributing to innovation and sustainable growth. Terumo Europe produces, distributes, markets, and sells a vast range of medical devices in five main business units: Interventional Systems, Pharmaceutical Solutions, Hospital Care Solutions, Cardiovascular and Life Care Solutions. Our headquarters are located in Leuven (Belgium). Terumo Europe committed to cultivating a globally diverse, equitable and inclusive culture. We empower everyone to bring their authentic self to work, which we believe leads to innovation that addresses the diverse healthcare needs of global society.

Arthrex APAC

Welcome to Arthrex…we are a global medical device company and leader in new product development and medical education in orthopedics. With a corporate mission of Helping Surgeons Treat Their Patients Better™, Arthrex has pioneered the field of arthroscopy and developed more than 1,000 innovative products and surgical procedures each year to advance minimally invasive orthopedics worldwide. Arthrex continues to experience unprecedented growth and demand for our products throughout the world; however, we remain a privately held company with a family business culture that is committed to delivering uncompromising quality to the health care professionals who use our products and, ultimately, the millions of patients whose lives we impact. Arthrex’s global headquarters is located in Naples, FL, with regional offices around the world in Munich, Germany (EMEA), Mexico City, Mexico (LATAM) and Singapore (APAC). Additionally, subsidiary offices and distribution centers are located throughout the Eastern and Western Hemispheres. We invite you to learn more about Arthrex and the positive contributions we are making to medicine and the communities we serve around the world. See Arthrex’s global locations: https://www.arthrex.com/corporate/locations Important Notices • None of our content is to be taken as medical advice. Please seek medical attention if you are experiencing symptoms. • Not all our products referred to are approved for use or available in your country. • Medical Education events are solely intended for healthcare professionals, unless otherwise stated. • By clicking on links, videos or graphics on this LinkedIn page, you may be directed to content managed by the Arthrex group. • Our products are only available for use by and sale to healthcare professionals. • Trademarks marked with the ® symbol are registered in the United States and may not be registered in your country.

Tandem Diabetes Care

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com. SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice. RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.